跳至主要内容
临床试验/NCT03248544
NCT03248544已完成不适用

Effect of Single High Dose Vitamin D3 on Peri-operative and Post-operative Complications and Clinical Outcomes in Patients Under Craniotomy for Brain Tumor Resection

Shahid Beheshti University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年7月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Vitamin D level

研究概览

简要总结

Vitamin D supplementation not only has beneficial effects on morbidity and mortality in critically ill patients but it may also lead to alleviate of seizure, brain edema, infection, pain and some other perioperative complications, possibly in part through an attenuation of the immune response.In this trial patients with brain tumor under craniotomy will receive a single high dose vitamin D compared to control group.

详细描述

A randomized, double blind, controlled trial will be conducted in neurosurgery ward, operating room (OR) and intensive care unit (ICU) in Tehran, Iran. After a full review of the inclusion and exclusion criteria and explanation of the risks and benefits of the study, written consent form will be completed. The participants are 60 eligible hospitalized patients that diagnosed with brain tumor and need to craniotomy, aged ≥ 18 years. Intervention patients will be received an intramuscular (IM) single dose of vitamin D (300000 IU). Patients will be evaluated for occurrence of perioperative complications and clinical outcomes immediately after surgery until 1 month later and 1 and 6 months mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent of patient or legal representative
  • 25(OH)D level below 20ng/dL

排除标准

  • Other trial participation, including previous participation in the pilot trial
  • Pregnant or lactating women
  • Hypercalcemia
  • Hyperphosphatemia
  • Tuberculosis
  • Sarcoidosis
  • History of nephrolithiasis
  • History of hyperparathyroidis
  • Medications that interfere with vitamin D metabolism
  • Renal Insufficiency

研究组 & 干预措施

vitamin D

Experimental

Intervention patients will be received a single dose of 300000 IU vitamin D via intramuscular injection

干预措施: vitamin D (Drug)

control

Other

Control patients will not be received any intervention

干预措施: control (Other)

结局指标

主要结局

Vitamin D level

时间窗: Postoperative day 5

25(OH) will be measured after surgery

次要结局

  • Duration of stay in ICU(30 days)
  • Duration of stay in hospital(30 days)
  • 1-month mortality(30 days)
  • 6-month mortality(6 months)
  • Peri-operative Complications(During surgery, recovery and hospitalization (5 days post op))
  • Post-operative Complications(30 days after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zahra Vahdat Shariatpanahi

Associate Professor

Shahid Beheshti University

研究点 (2)

Loading locations...

相似试验